Cleared Traditional

K160081 - TENS Electrodes

K160081 is an FDA 510(k) clearance for TENS Electrodes, manufactured by Cathay Manufacturing Corp.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 278-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
278d
Days
Class 2
Risk

K160081 is an FDA 510(k) clearance for the TENS Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Cathay Manufacturing Corp. (Shanghai, CN). The FDA issued a Cleared decision on October 19, 2016 after a review of 278 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K160081

510(k) Number K160081 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2016
Decision Date October 19, 2016
Days to Decision 278 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 149d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Shanghai Yuntao Management Consultant
Fan Tao

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 358
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K160081.
Complete Control System
K162891 · Coapt, LLC · Apr 2017
MaxxiGold Electrode 48, MaxxiGold Electrode 60, MaxxiGold Electrode 96
K163547 · Neurovirtual USA, Inc. · Apr 2017
FlexStim Neurostimulation Electrodes Model Numbers: 5050ROC1S, 5050ROC1W, 5050ROC2S, 5050ROC2W, 5050SQC1S, 5050SQC1W, 5050SQC2S, 5050SQC2W
K161282 · Medico Electrodes International , Ltd. · Oct 2016
Adhesive Electrodes
K160138 · Gmdasz Manufacturing Co., Ltd. · Aug 2016
Disposable Adhesive Surface Electrodes, Disposable/Reusable Cup Electrodes
K153019 · Bio Protech, Inc. · Mar 2016
Mailuokang Self-adhesive Electrode
K152815 · Shenzhen Mailuokang Technology Co., Ltd. · Mar 2016